AgeX Therapeutics, Inc. Gains 38.18%
AgeX Therapeutics, Inc. (AGE:NYSEMKT) jumped higher at $1.52, representing a gain of 38.2%. The stock appeared on our News Catalysts scanner on Mon 27 Jul 20 at 06:10 PM in the 'PATNERSHIP' category. From Mon 20 Jul 20, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Tue 21 Jul 20 at $1.66 with a volume of 2M+.
About AgeX Therapeutics, Inc. (AGE:NYSEMKT)
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop innovative medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1 and AGEX-BAT1. And iTR drug-based therapeutic candidates in development are AGEX-iTR1547 and Renelon.
Top 10 Gainers:
- Alterity Therapeutics Limited (ATHE:NASDAQ), 154.07%
- SilverSun Technologies, Inc. (SSNT:NASDAQ), 96.36%
- Sintx Technologies, Inc. (SINT:NASDAQ), 53.05%
- Whiting Petroleum Corporation (WLL:NYSE), 40.26%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 39.17%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 38.18%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 32.63%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 31.42%
- Technical Communications Corporation (TCCO:NASDAQ), 29.89%
- Ossen Innovation Co., Ltd. (OSN:NASDAQ), 29.75%